- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04544930
Therapist-guided Internet Treatment for Hazardous and Harmful Alcohol Use. A Feasibility Study
Therapist-guided Internet Treatment for Hazardous and Harmful Alcohol Use. a Feasibility Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background:
A significant proportion of people with substance abuse do not seek help for their problems and therefore do not receive the necessary help at an early stage. An important reason for this is the stigma associated with substance abuse. Therapist-guided Internet treatment has been developed and tested in recent years as an approach that increases access to effective treatment for a variety of mental and substance-related problems and disorders. Internet-based interventions increase the patient's choice of type of treatment and give the patient an experience of having control over their own behavior change. Moreover, such treatment is independent of where you live, and you do not need to attend a clinic. In addition, by offering therapist-guided Internet treatment, therapists can treat far more patients compared to regular face-to-face treatment. In this way, the health services, which are already under severe pressure due to many new and competing tasks, are relieved.
Research questions:
- Is therapist-guided Internet treatment for hazardous and harmful alcohol use feasible for self-referred persons?
- What factors contribute/do not contribute to the feasibility of treatment?
- Can the intervention help people change risky drinking habits before it develops into problems that are more serious?
- How do participants experience the intervention?
Methods:
Participants:
A total of 30 participants will be recruited through announcements in social media, newspapers and through GP's and other health care services. Participants will be recruited from the catchment area of Haukeland University Hospital, Western Norway, and Vestfold Hospital, Eastern Norway.
Design:
The study will be conducted as an open, 6-months follow-up study, to assess whether the design is suitable for a randomized controlled trial in the next round. Both quantitative and qualitative methods will be used to investigate the feasibility of the treatment program.
Data collection:
Assessments will be carried out at start of treatment (T1), through the treatment course (T2) and at the end of treatment (T3) and at follow-up (T4). Qualitative interviews will be conducted at the end of treatment.
Intervention:
The treatment program is developed at Vestfold Hospital, Norway. It is based on Internet- based cognitive behavior therapy (ICBT). The treatment program consists of eight text-based self-help modules on the Internet that participants can access via secure login using Bank identification (ID) (security level 4). The self-help modules include psychoeducation, tasks and exercises. The therapist guidance is secondary to the self-help modules. The therapist provides feedback to the patient online in the secured program once a week.
Statistics:
Sample size:
Since this is a feasibility study primarily intended to test the feasibility of therapist-guided Internet treatment for hazardous and harmful alcohol use, the sample will be limited to 30 participants. Therefore, power analysis is not performed.
Statistical methods:
Both statistical and interpretative methods will be used. Descriptive statistics (percentages, means, standard deviations), as well as statistical and clinical change. Qualitative in-depth interviews will be analyzed using thematic content analysis.
Plan for activities and dissemination:
Scheduled start of data collection is September 2020. The data collection will continue until the summer of 2021. The follow-up period will be completed by the end of 2021.
The results of the feasibility study will be published in peer-reviewed journals. Furthermore, the results will be disseminated to the public through media (including social media), and as information aimed at both health and social care professionals, patient groups and user forums.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bergen, Norway, 5021
- Haukeland University Hospital
-
Tønsberg, Norway, 3103
- Vestfold Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18 years or older
- access to the Internet
- interested in receiving Internet treatment for changing drinking habits
- a score of 6 or higher for women and 8 or higher for men on the Alcohol Use Disorder Identification Test (AUDIT)
Exclusion Criteria:
- diagnosed alcohol dependence or addiction to other drugs and already in treatment
- serious reading and/or writing difficulties
- cognitive impairment/dementia
- severe mental disorder or in need of other treatment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: therapist-guided
Therapist-guided Internet treatment based on cognitive behavior therapy (ICBT).
|
Therapist-guided Internet treatment comprises eight text modules on the Internet that include psychoeducation, tasks and exercises.
Key elements are setting goals for treatment, identifying and challenging negative automatic thoughts through a number of exercises and behavioral experiments, as well as making a plan for relapse prevention.
Therapist guidance is secondary to the self-help modules, and the therapist provides feedback to the patient online in the secured program once a week
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Alcohol Use Disorders Identification Test (AUDIT)
Time Frame: AUDIT will measure whether there is a change in alcohol intake during the treatment period (8-12 weeks) and at follow-up (6 months after the end of treatment).
|
AUDIT is a screening instrument consisting of 10 questions designed to identify hazardous (risky) and harmful use of alcohol in adults.
Based on the 10 questions, a score is calculated indicating whether the person is at risk for developing more serious alcohol problems.
A cut-off score of > 6 points indicates risky use in women, and a cut-off score of > 8 points indicates risky use in men.
|
AUDIT will measure whether there is a change in alcohol intake during the treatment period (8-12 weeks) and at follow-up (6 months after the end of treatment).
|
|
The Timeline Followback (TLFB) for alcohol
Time Frame: TLFB will calculate the intake of alcohol units (AE) and change in the seven-day period from the first assessment to the 6 months follow-up.
|
TLFB for alcohol is an assessment tool that includes estimates of daily alcohol intake over a specific period, e.g.
within seven days.
TLFB provides information on various dimensions of the person's drinking habits, such as the number of drinking days and the maximum amount of alcohol consumed.
|
TLFB will calculate the intake of alcohol units (AE) and change in the seven-day period from the first assessment to the 6 months follow-up.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Drug-Taking Confidence Questionnaire (DTCQ).
Time Frame: DTCQ will measure changes during the treatment course of 8-12 weeks, and at 6 months follow-up.
|
DTCQ measures the person's confidence in his or her abilities to cope in situations that are high-risk for substance use.
The tool yields information about client strengths and needs in the area of relapse potential in 50 different risk situations.
|
DTCQ will measure changes during the treatment course of 8-12 weeks, and at 6 months follow-up.
|
|
Symptom Checklist -10 (SCL-10)
Time Frame: SCL-10 will measure changes in psychological distress during the treatment course of 8-12 weeks, and at 6 months follow-up.
|
SCL-10 is a self-report questionnaire for identifying symptoms of psychological distress over the past seven days.
SCL-10 contains 10 statements.
|
SCL-10 will measure changes in psychological distress during the treatment course of 8-12 weeks, and at 6 months follow-up.
|
|
Patient Health Questionnaire, PHQ-9
Time Frame: Patient Health Questionnaire (PHQ-9) will measure changes in symptoms of depression during the treatment course of 8-12 weeks, and at 6 months follow-up.
|
Patient Health Questionnaire (PHQ-9) consists of nine items and measures key symptoms of depression.
|
Patient Health Questionnaire (PHQ-9) will measure changes in symptoms of depression during the treatment course of 8-12 weeks, and at 6 months follow-up.
|
|
General Anxiety Disorder (GAD-7).
Time Frame: GAD-7 will measure changes in symptoms of anxiety during the treatment course of 8-12 weeks, and at 6 months follow-up.
|
GAD-7 is a screening instrument that consists of seven items and measures key symptoms of anxiety.
|
GAD-7 will measure changes in symptoms of anxiety during the treatment course of 8-12 weeks, and at 6 months follow-up.
|
|
EuroQol five-dimensional (EQ-5D) descriptive system (EQ-5D-5L)
Time Frame: EQ-5D-5L will measure changes in health-related quality of life during the treatment course of 8-12 weeks, and at 6 months follow-up.
|
EQ-5D-5L measures health-related quality of life in five areas; mobility, personal care, activities of daily living, pain/discomfort and anxiety / depression
|
EQ-5D-5L will measure changes in health-related quality of life during the treatment course of 8-12 weeks, and at 6 months follow-up.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Qualitative interviews
Time Frame: Qualitative interviews will be conducted at the end of treatment, immediately after 8-12 weeks completed treatment
|
Qualitative interviews will investigate participants' expectations and experience of the intervention, focusing on both the technical solutions related to the intervention and the importance of therapist support.
|
Qualitative interviews will be conducted at the end of treatment, immediately after 8-12 weeks completed treatment
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Else Marie Løberg, PhD, Haukeland University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 31352
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Abuse
-
BrainswayRecruitingAlcohol Dependence | Alcoholism | Alcohol Use Disorder | Alcohol Abuse | Alcohol Addiction | Alcohol Abuse/DependenceUnited States, Israel
-
The Morton Center, Inc.National Institute on Alcohol Abuse and Alcoholism (NIAAA)UnknownAlcohol Dependence | Cannabis Dependence | Alcohol Abuse | Cannabis Abuse | Other Substance AbuseUnited States
-
Michael E. DeBakey VA Medical CenterUnknownAlcohol Dependence | Alcohol Abuse | Substance Abuse ProblemUnited States
-
Polaris Health DirectionsUniversity of Massachusetts, WorcesterCompletedAlcohol Abuse, Alcohol DependenceUnited States
-
Australian National UniversityUniversity of Peradeniya; Department of Foregin Affairs and Trade, AustraliaCompletedIntimate Partner Violence | Domestic Abuse | Drug and Alcohol AbuseAustralia
-
Kent State UniversityCompletedAlcohol Use Disorder | Alcohol Abuse | Alcohol Abuse, EpisodicUnited States
-
National Institute on Drug Abuse (NIDA)CompletedDrug/Substance Abuse/Addiction | Alcohol Abuse/AddictionUnited States
-
University of Southern CaliforniaNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingAlcohol Consumption | Alcohol Abuse/DependenceUnited States
-
Queen Mary University of LondonBarts & The London NHS Trust; University of HertfordshireCompletedAlcohol Use Disorder | Alcohol Abuse or DependenceUnited Kingdom
-
Gulhane School of MedicineRecruitingAlcohol Abuse/DependenceTurkey
Clinical Trials on therapist-guided
-
Karolinska InstitutetRegion StockholmCompletedInsomnia | Major Depression | Minor DepressionSweden
-
Rush University Medical CenterCompleted
-
Children's Hospital Medical Center, CincinnatiPatient-Centered Outcomes Research Institute; Children's Hospital Colorado; Nationwide... and other collaboratorsCompletedWounds and Injuries | Brain Injuries | Craniocerebral Trauma | Trauma, Nervous System | Brain Concussion | Head Injuries, Closed | Head Injury | Brain Edema | Disorders of Environmental Origin | Brain Hemorrhage, Traumatic | Subdural Hematoma | Epidural Hematoma | Intracranial Edema | Tbi | Cortical ContusionUnited States
-
Ruya Gul TemelCompletedCerebral PalsyTurkey
-
University of Texas at AustinCompletedDepressive SymptomsUnited States
-
Massachusetts General HospitalKoa Health B.V.Completed
-
Karolinska InstitutetRegion StockholmCompleted
-
Uppsala UniversityLinkoeping University; Utah State University; Friedrich-Alexander-Universität...RecruitingPremenstrual Dysphoric DisorderSweden
-
NYU Langone HealthAmerican Occupational Therapy FoundationCompleted
-
Sultan Qaboos UniversityThe Research Council; Oman Medical Specialty BoardUnknownDepressive Symptoms | Generalized Anxiety